chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1/12/21 1:00 AM violent chills, 5:00 AM temperature 102.6, took Acetaminophen.  Exhaustion, throbbing joints. 2:00 PM temperature 101.8, took Acetaminophen,  chills, headache, horrible pounding joint pain. 7:00 PM temperature 100.9, chills and exhaustion, took Acetaminophen .  1/13/21 4:00 AM,  chills, temperature 100, took Acetaminophen.  9:00 AM exhaustion, massive body aches. 4:00 PM temperature 98.9, chills, exhausted.  Have slept about 36-40 hours and lost 2 days of work.
Underneath the injection site was pink; Sore arm; Rash at different part of his body; Underneath the injection site was itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (Underneath the injection site was pink), PAIN IN EXTREMITY (Sore arm), RASH (Rash at different part of his body) and VACCINATION SITE PRURITUS (Underneath the injection site was itchy) in an 89-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced VACCINATION SITE DISCOLOURATION (Underneath the injection site was pink), PAIN IN EXTREMITY (Sore arm), RASH (Rash at different part of his body) and VACCINATION SITE PRURITUS (Underneath the injection site was itchy). The patient was treated with TRIAMCINOLONE ACETONIDE for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE DISCOLOURATION (Underneath the injection site was pink), PAIN IN EXTREMITY (Sore arm), RASH (Rash at different part of his body) and VACCINATION SITE PRURITUS (Underneath the injection site was itchy) outcome was unknown.            No concomitant medications were reported.
New diagnosis of paroxysmal of Afib March 21, 2022.  Treatment included anticoagulatant, Cardioversion, Metoprolol BID. Ablation has been scheduled for May 20.
Patient received 0.3 ml Pfizer vaccination by nurse. Placed in 30 minute monitoring area.  At 1:20PM patient complained of feeling shortness of breath and pressure in her chest. Pt taken to the medical observation area by RN. Vital signs taken as follows: B/P 217/121 mm Hg, HR 73 bpm, 02 Sat 99%. Pt stated she has hypertension and prescribed two types of hypertension medication but did not take her medicine today. EMS activated by EMT. EMS arrived and transported pt to hospital.
Tired, stomach pain, headache, arm pain, muscle cramps, 24 hours.
54 y.o. male patient of Physician No with history of esophageal varices (last banding 1 year ago), decompensated alcoholic cirrhosis, hepatitis C and HTN. Transferred from Hospital where he initially presented for large volume hematemesis followed by subsequent cardiac arrest, managed in the ICU eventually transferred to the floor. He left AMA saying he had a rehab place line up. He left despite worsening liver failure and without any appropriate follow ups arranged.        Decompensated Alcoholic Cirrhosis Hepatitis C Unable to verify extent of alcohol use, was previously sober for 9 months in 2020 but unclear if still drinking Home meds: propranolol, spironolactone, Hep C quant and Ab positive 2020, unclear if treated Repeat Hep C quant 605,000 IV thiamine  Encourage cessation, consider addiction med c/s  Rising T bili 0.5-- >2.6,  rising AST 54-- >107, ALT wnl, will re-consult GI Patient wants to leave but parameters heading in the wrong direction. He eventually signed out AMA knowing the risk. He appeared to have capacity.    Cardiac Arrest Suspect 2/2 to hypovolemic shock from esophageal variceal bleeding vs profound acidosis  ROSC obtained after two rounds of CPR, Ca, Epi, and Bicarb S/p 2u pRBC EKG no ischemic changes  Wean sedation and ventilation as tolerated Post cardiac arrest protocol initiated: Target temperature management, CT head pending, EEG Cardio consulted, signed off 12/29 No further testing per cardiology  Neurology consulted, signed off 12/29   Upper GI bleed Acute blood loss on chronic anemia  Esophageal varices, secondary to alcoholic cirrhosis as below  Patient with history of varices, last banding one year ago; now presenting with large volume hematemesis prior to cardiac arrest, see above.  On admission Hgb 11.7, b/l 9.1-10.6 CTA abd/chest/pelvis with no signs of active bleeding  S/p 2U pRBC, protonix bolus On Octreotide gtt, discontinued 12/30 S/p CTX in ED for CAP, see below, will continue for SBP prophylaxis Rocephin and Protonix IV x 5 days  Gastroenterology consulted EGD 12/28 + stigmata of recent esophageal variceal bleed, s/p band x5 IF rebleeds from varices will need VIR for emergent TIPS  Okay from GI for diet  Was tolerating diet prior to discharge.  Acute Hypercapnic respiratory failure Multifocal Pneumonia COVID-19 2/2 cardiac arrest in the setting of acute COVID infection and imaging c/f CAP Currently sedated and on ventilator Continue dilaudid and propofol gtt, added precedex 12/29 as weaning off other medications  Continue Azithro/CTX for CAP coverage Steroids and remdesivir  Legionella and strep pneumo antigen negative  MRSA nares positive  Blood Cx prelim negative Extubated 12/30 on NC  PRN cough suppressants for comfort
Pt reports soreness to left arm injection site since 6/15/08 and onset of several red blotches to left arm around injection site accompanied with 2 water like blisters to left arm-one above left wrist and one to anticubital left arm noted 6/18/08.
Central Retinal Artery Occlusion, Right Eye  Occurred 4 days after vaccination Negative systemic work-up
Immunocompromised patient received 0.25ml for the 3rd dose and should have received 0.5ml; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (Immunocompromised patient received 0.25ml for the 3rd dose and should have received 0.5ml) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 ml. On 22-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ACCIDENTAL UNDERDOSE (Immunocompromised patient received 0.25ml for the 3rd dose and should have received 0.5ml). On 22-Oct-2021, ACCIDENTAL UNDERDOSE (Immunocompromised patient received 0.25ml for the 3rd dose and should have received 0.5ml) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided Treatment medications were not provided
Taken her 2nd dose of the Moderna vaccine and she is experiencing fast heartbeats; Itching that she has; Left arm swelling at the injection site and she feels that the swelling; This spontaneous case was reported by a nurse and describes the occurrence of HEART RATE INCREASED (Taken her 2nd dose of the Moderna vaccine and she is experiencing fast heartbeats), PRURITUS (Itching that she has) and VACCINATION SITE SWELLING (Left arm swelling at the injection site and she feels that the swelling) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 063A21A and 021B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEART RATE INCREASED (Taken her 2nd dose of the Moderna vaccine and she is experiencing fast heartbeats), PRURITUS (Itching that she has) and VACCINATION SITE SWELLING (Left arm swelling at the injection site and she feels that the swelling). At the time of the report, HEART RATE INCREASED (Taken her 2nd dose of the Moderna vaccine and she is experiencing fast heartbeats), PRURITUS (Itching that she has) and VACCINATION SITE SWELLING (Left arm swelling at the injection site and she feels that the swelling) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment information was not provided. Action taken with the drug in response to the event is not applicable.
3RD DOSE OF PFIZER COVID VACCINE GIVEN 8/16/21, LOT #0698057;  pt had a positive COVID test on 7/7/22 and passed away in his home on 7/13/22
This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a patient who received SHINGRIX. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was unknown. It was unknown if the reporter considered the influenza-like symptoms to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient was the reporter and refrained from providing any information.
Initial information received on 20-Sep-2018 regarding an unsolicited valid serious case received from a Nurse via sales representative. This case involves a male patient (age was not reported) (reporter's father) who experienced severe myalgia, extreme fatigue and he could barely lift his head, while he received vaccine FLUZONE HIGH DOSE. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date (reported as sometime in the last 2 weeks), the patient received a 0.5 ml of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE lot number not reported. On an unknown date ¸the patient developed a serious severe myalgia, extreme fatigue and the patient could barely lift his head  following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE. This event was assessed as medically significant. The patient didn't experience any fever. No lab data reported. Final diagnosis was barely lift his head, extreme fatigue duration was two-days and severe myalgia (duration was two-days). It was not reported if the patient received a corrective treatment. The patient outcome is reported as Recovered / Resolved on an unknown date for severe myalgia (lasted for two days), as Recovered / Resolved on an unknown date for extreme fatigue (lasted for two days) and as Unknown for he could barely lift his head.; Sender's Comments: This case involves an elderly male patient who experienced myalgia, fatigue and head discomfort after vaccination with FLUZONE HD. Time to onset is unknown. However, further information including patient's medical history, condition at the time of vaccination, laboratory investigations excluding other etiology would be needed to fully assess this case. Based on available information the role of vaccine cannot be assessed.
Patient presented to emergency department on 9/7/2021 with cough and shortness of breath. She had tested positive for COVID-19 on 9/2/2021 at a different facility. She was admitted to a different hospital from 8/4 to 8/13 with pneumonia. She was admitted for further management. She was treated with remdesivir, dexamethasone and supplemental oxygen. She was discharged on 9/22/2021 to inpatient rehab facility.
Near syncope episode and vomited.  She was assessed by the nurse - no vitals or bp.  Cold cloth given. Recovered quickly and felt fine so the family left.  I called the home approx.  2 hours later and spoke with dad, she was doing well at that time.
PATIENT WAS 5 YEARS OLD AND RECEIVED COMIRNITY 0.3MCG/0.2ML DOSE. NO ADVERSE OUTCOMES HAVE BEEN DOCUMENTED
Swollen and tenderness under armpit (same arm as vaccine).  Occurred about 1 week after vaccination.
sore arm; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and FATIGUE (fatigue) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and FATIGUE (fatigue). At the time of the report, PAIN IN EXTREMITY (sore arm) and FATIGUE (fatigue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.Treatment medication was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-098529, US-MODERNATX, INC.-MOD-2021-097451 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-098529:Case for dose 2 US-MODERNATX, INC.-MOD-2021-097451:cross linked case
Patient felt nauseated, diaphoretic, tingling sensation in mouth. Patient watched and recovered at site
Information has been received from a Registered Nurse concerning a female patient in her 70's who on approximately 14-NOV-2008 was vaccinated iwth PNEUMOVAX 23 (Lot # was not available), 0.5ml. On approximately 15-NOV-2008 the patient experienced cellulitis on her forearm. After 3 days the patient had the symptom she recovered on approximately 18-NOV-2008. The patient sought medical attention with the physician and nurse. No further information is available.
Patient was given the J&J vaccine but she was not yet 18 years old (DOB 10/6/03)
On July 28, 2022, after my booster I experienced body aches, diarrhea, stomach cramps and fever.  Throughout the night it progressed.  Fever broke Monday.  The next week I thought I would be fine, but the diarrhea was still present.  I went out with some friends during the week and needed to go to have a bowel movement, but I did not make it to the bathroom in time.  I have taken over the counter medications to help stop the diarrhea, but it has not resolved.  I began using two types of homeopathic remedy and that has not helped.  I can eat but only bland foods with small meals.  I have a doctor?s appointment on September 16, 2022.
2 hours post vax, the pt got "crabby", began crying inconsolably, had a hard red lump at the injection site. The pt developed a 100.6 fever, had fever the complete next day. By the third day the pt had a fever of 102. Symptoms resolved on
Pt. states that after receiving the 1st dose of Phizer 08/28/2021, started experiencing symptoms @ 3:00 am 08/29/2021 of heart palpations (10mins) , numbness and tingling from mid-back to mid-calf (lasting 1-2hrs), and lingering dull headache. Primary communications (no outcome). Continuing to experience lingering dull headache.
Over a year late for 2nd dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included shingrix (received 1st dose on an unknown date).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 22-Feb-2023 Reporter's Comments:  Pharmacist states that some patients were over a year late with getting their 2nd dose of Shingrix.  She states that they either weren't told that they need to get a 2nd dose or they forgot. The reporter consented to follow up via postal. HCP did not have an exact number of patient or demographics currently.  Additional Supportive Information: Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
2/12/21 - RECEIVED MODERNA DOSE #1 - 8 hours after vaccination, MILD ARM SORENESS (no analgesics needed) 2/19/21 - (1 WEEK AFTER DOSE #1) - Experienced a general MALAISE all day, which then progressed into a feeling of being "OUT OF BREATH"  when walking about. SYMPTOMS WERE GONE BY THE VERY NEXT MORNING.  3/12/21 - RECEIVED MODERNA DOSE #2 - 2-1/2 hours after vaccination, MILD FEVER (1-2 DEGREES ABOVE NORMAL) and FATIGUE for about 3 hours. Symptoms subsided after taking Tylenol. 3/13/21 - SORE ARM beginning in morning; slight feeling of being "warm", but no fever shown on thermometer. Continued to take Tylenol, which mitigated any symptoms.  AS OF 3/15/21, NO FURTHER SYMPTOMS PRESENT, AND FEEL JUST FINE!
Redness, swelling, pain in Left arm, radiating up into neck. Treatment on 04/26/2010: Rx for Bactrim DS 1 b.i.d x 10 days, told to apply ice.
(L) arm with 14 x 12 cm redness 11/28/12, 7 cm redness & 5 cm induration 11/27/12. Positive pain 11/27/12 but less pain 11/28/12. Positive hot to touch. Positive itchiness.
stomach hurt; wanting to threw up; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (stomach hurt) and NAUSEA (wanting to threw up) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 069h21a, 032b21a and 031b21a) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In December 2021, the patient experienced ABDOMINAL PAIN (stomach hurt) and NAUSEA (wanting to threw up). At the time of the report, ABDOMINAL PAIN (stomach hurt) and NAUSEA (wanting to threw up) outcome was unknown.            No concomitant medications was provided. No treatment medications was provided.   This case was linked to MOD-2021-424319 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Dec-2021: Non significant follow-up appended.
Patient came into the pharmacy exactly a week after his vaccines and said his right arm where he got his flu shot swelled up and he had a grapefruit sized rash. He says he's never reacted to a flu shot like that before (this is his first time getting Fluzone HD)
pt recv vax 31OCT97 & 9NOV97 pt to MD w/40-50 lesions on knee w/in a congenital hairy nevus;also had approx 2-3 lesions on abd;MD felt that the lesions may have been caused by vax;
PATIENT STATES THE AREA AS WARM TO THE TOUCH, RAISED WITH A 2" DIAMETER AT THE PEAK OF SYMPTOMS
The administer of the shot gave it to me way outside of the "triangle" and I immediately felt a burn in my forearm muscle.  Just thought it was a coincidence.  Then while driving home the one side of my hand started to go numb, my ring finger, pinky and down the left edge went numb and is still numb to this day.  My forearm hurt for a few day with a burning sensation.  I could barely lift my arm without getting a stabbing pain in my shoulder.  This lasted for about 3 or 4 days?  2 months later my toes went numb and then after that a numb sensation from head to toe in addition to shooting pains all over my body.  Burning pain in my feet and cramping in calves.  I have face numbness and my brain is foggy.  I've been to the ER twice and am seeing a neurologist and a back doctor and am in the process of getting several tests done.  I've had a brain MRI, Lumbar MRI and am getting a neck MRI next.
Information has been received from a pharmacist concerning a patient who on unspecified date, was vaccinated with a dose of PNEUMOVAX 23 (lot number, dose and site of administration not reported). It was reported that on unknown date, the patient experienced significant pain and swelling at the injection site and had fever and fatigue. The patient received unspecified medical attention. At the time of the report, the patient had recovered (date unspecified). Additional information has been requested.
RED, ITCHY RASH COVERING BOTH ARMS, BACK, NECK, SHOULDERS, CHEST, AND FACE. SEVERE FATIGUE.
sore arm, large red spot below shot, severe body ache, fatigue, headache, moderate fever, chills, burn during urination
NOT AN ADVERSE EVENT. ERROR DONE BY GIVING MODERNA THAT IS 2 DAYS BEYOND USE DATE IN THE REFRIDGERATOR. CALLED MODERNA TO FOLLOW UP AND IF WE WILL NEED TO RE-VACCINATE PT. PT HAS NOT ISSUES OR ADVERSE EFFECTS AT THIS TIME.
Fever, chills. Hot flashes. Stomach pain, body aches, headache, tiredness, weakness. Shot dates: 8/3 - 8/6 - 8/10.
Developed fever 4/24/07. The injection site of Varivax had 4" round induration that was hot, painful.
Vaccine administration date 2/12/2007, varicella dose #2 and Gardisil dose #1 administered concurrently. No symptoms until March 4th when in AM noted by mother to have a cold/URI symptoms with cough. Emesis at 11 after soup at 10, napping when mom at home at 3 PM but difficult to arouse. Called 911 and started rescue breathing. Paramedics initially called in stable VS's but required active CPR on gurney by time came into ED.  In disorganized vfib in ER-resusc'd with PALS then consulted cardiology for ECMO.  Cannulated for VA ECMO - on full flow support after 1.5 hours. Heart completely akinetic. Went to cath lab to get biopsies, CAD's and assessment of integrity of heart with very poor tone/strength to heart muscle noted; presumed acute viral myocarditis. Has gotten IVIG. Can't assess neurologic function due to significant drug load. Remains with very disorganized rhythym today; to consider EPS study; also studying family for possible inherited rhythym disturbances. 03/20/07-partial records received from facility, patient remains in hospital. Received ECMO support for cardiac arrest secondary to myocarditis. Endomyocardial biopsy: acute lymphocytic myocarditis with scattered eosinophils.  04/25/07-DC Summary received for DOS 03/04-03/23/07-DC DX: Cardiac arrhythmia. Myocarditis.  Per information received from annual follow up, off all CHF medications; very minimal residual orgainc brain syndrome; responding to PT/OT & counseling.
Seizure, high pitch cry, runny nose, fussy. 5/10/02 at 1:00PM.
Initial case received on 25 October 2006 from a health care professional.  A 43-year old female patient, with a history of asthma and allergy to peanuts, had received a left deltoid, intramuscular injection of Fluzone SV 2006-2007, on 18 October 2006.  At an unspecified time post-vaccination, the patient developed a three inch swollen red area.  She complained it was hot and swollen; and, once the redness subsided, she complained of pruritus.  At the time of this report, recovery status was unknown.  Follow-up information received on 29 May 2007 from the patient who is a physician.  The patient had no illnesses at the time of the vaccination on 08 October 2006.  No relevant diagnostic tests or laboratory data were performed for the adverse events.  It was reported that the patient recovered from these adverse events (date of recovery was not provided).  No further information is expected.